Oura Acquires AI Primary Care Startup Counsel Health for $625M
By Ali Al-Montaser — Senior AI Technical Editor
Oura announced Tuesday it will acquire AI-native primary care startup Counsel Health for $625 million, with the deal expected to close before the end of 2027. The move follows Oura's postponed IPO targeting $2.2 billion and the June integration of Counsel's medical AI into the Oura app. Oura reported $533 million in quarterly revenue (up 153% YoY) and $1.75 billion for fiscal 2026 (up 92%), at an $11 billion valuation after a $900 million raise in October 2025.
Executive Overview
Oura announced on Tuesday its acquisition of Counsel Health, an AI-native primary care startup, for $625 million, with the deal expected to close before the end of 2027. The announcement comes weeks after Oura postponed its initial public offering, which had targeted raising $2.2 billion, and follows the June integration of Counsel's service into the Oura app. The deal marks a strategic expansion from physiological tracking into full-spectrum healthcare delivery, spanning preventive, acute, specialty, and chronic care.
📊 Official Data & Technical Specifications Card
| Technical Axis | Confirmed Official Data |
|---|---|
| 💰 Pricing & Usage Cost | Acquisition value: $625 million. Counsel Health funding: $25 million Series A led by a16z and GV, with total funding of $36 million per PitchBook. No separate subscription pricing for Counsel within the Oura app was disclosed in the announcement. |
| 🌐 Platforms & Immediate Availability | Service fully integrated into the Oura app since June 2026, and continues to serve existing and new enterprise partners following the acquisition. |
| ⚡ Performance & Speed Metrics | Oura revenue growth of 153% year-over-year for the quarter ended September 30, 2026 ($533 million), and 92% growth for fiscal year 2026 ($1.75 billion). |
| 🛡️ Security & Breach Resistance | Counsel affirms that medical AI is built on trust, safety, and accountability, keeping physicians in the loop for clinical decisions. |
| 🧠 Context Window | Not disclosed in the announcement. The service relies on Oura biometric data, trends, and user engagement to provide objective clinical context for physicians. |
| 🌍 Arabic Language & Regional Support | The announcement did not mention explicit Arabic language support or availability in specific countries. The service is primarily aimed at Oura members and enterprise partners. |
Deep-Dive Features & Architecture
Counsel Health's platform combines a conversational medical experience with access to licensed physicians. Since its integration into the Oura app in June, users have been able to interact with medical AI for personalized health advice and then speak with a doctor when needed, all within the same app. The two companies now plan to expand the partnership to cover preventive care, acute care, specialty care, and chronic care, transforming Oura from a physiological tracker into a healthcare entry point.
Tom Hale, CEO of Oura, said Oura helps members understand their physiology, and with Counsel they can take health actions including quick questions, prescriptions, lab results, chronic care, and referrals. Muthu Alagappan, CEO of Counsel, emphasized that Oura's data gives physicians objective context, tracked biometrics, and member engagement to make more informed decisions. After the deal, Alagappan will join Oura as chief clinical AI officer, along with 70 Counsel employees.
Benchmark & Competitive Performance
Oura has dominated the smart ring market for years, but competitors like RingConn and Ultrahuman are pressuring its share, pushing it to expand beyond tracking hardware. Comparing the numbers, Oura generated $533 million in a single quarter with 153% growth, $1.75 billion annually with 92% growth, and an $11 billion valuation after a $900 million round in October 2025. In contrast, Counsel Health had raised only $36 million before the acquisition, making the $625 million price a significant multiple that reflects the value of clinical integration and data more than current revenue.
Industry Impact & Enterprise Adoption
The acquisition signals a broader shift in the wearables industry from passive tracking to active clinical intervention. By embedding licensed physicians and AI-driven triage directly into its app, Oura positions itself as a primary care gateway rather than a fitness accessory. For enterprise partners, the expanded service offers a scalable model for employee health benefits, combining continuous biometric monitoring with on-demand medical consultations. The deal also intensifies competition with platforms like Amazon Clinic and Teladoc, which have pursued similar integrations of virtual care and remote monitoring.
For developers and the Arabic-speaking market, the announcement includes no commitment to Arabic language support or availability in Arab markets, meaning users in the region will likely remain outside the service's scope in the near term. The key lesson for Arab developers is that the value of medical AI comes not from the model alone but from integrating biometric data, clinical compliance, and physician involvement. Regional startups will need to build cost models based on tokens and licensed medical consultations, while any Oura expansion into the region could impose local privacy and language standards.
Conclusion
The $625 million acquisition represents a strategic transformation for Oura, moving it from a hardware-centric wearables company into a vertically integrated healthcare platform. With strong revenue growth, a substantial valuation, and a clear integration roadmap, Oura is betting that the future of preventive health lies in combining continuous biometric data with AI-assisted clinical care. The deal's success will depend on regulatory navigation, physician adoption, and the company's ability to scale Counsel's model beyond its current enterprise partnerships.
Media Source: TechCrunch AI | Fact Verification & Analysis: AI Tools Oasis
Frequently Asked Questions
$625 million. Oura officially announced the deal on Tuesday, and it is expected to close before the end of 2027.
Oura recorded $533 million in revenue for the quarter ended September 30, up 153% year-over-year, and $1.75 billion for fiscal year 2026, up 92%. Its valuation reached $11 billion following a $900 million funding round in October 2025.
Counsel Health raised $25 million in a Series A led by Andreessen Horowitz and GV, with PitchBook estimating total funding at $36 million.
The partnership, in place since June 2026, will expand to cover preventive, acute, specialty, and chronic care, while medical chat, prescriptions, lab results, and referrals remain within the Oura app.
Muthu Alagappan, CEO of Counsel Health, will join Oura as chief clinical AI officer, along with 70 Counsel employees.
AI Tools Oasis Team
Bringing you the latest news and analysis in the world of Artificial Intelligence with accuracy and credibility. Follow us for all updates.
